cisplatin,gemcitabine,nivolumab
bms
['gu ', 'mibc', 'hcrn,gu,16-257', ' cis ', ' gem ', 'nivo', 'bladder']
#ascogu23 outstanding trial by surgery for all cr #bladdercancer patients after neo?
my be not hcrn gu 16-257: neo gem + cis + nivo with selective bladder sparing in p. cancer mibc
43 % cr - long term bladder intact mfs! 
Uro Oncology
Jeshbon ha-nefesh
Buenos Aires 
Argentina